June 20, 2019 by Chain Drug Review
DIR fees, NACDS, President Donald Trump
Leading Headlines, Pharmacy

WASHINGTON — Nearly a quarter of the House of Representatives – 105 members – has sent a letter to President Donald Trump noting the “missed opportunity” to reduce seniors’ out-of-pocket costs for prescription drugs. This missed opportunity occurred when pharmacy direct and indirect remuneration (DIR) fee reform was excluded from a recent Medicare rule. The legislators,
June 4, 2018 by Jeffrey Woldt
prescription drug prices, President Donald Trump
Issue 06-04-2018, Opinion

President Trump has unveiled the administration’s much anticipated plan to reduce pharmaceutical prices. Speaking in the White House Rose Garden last month, the president touted what he characterized as “the most sweeping action in history to lower the prices of prescription drugs for the American people.” Long on rhetoric and short on specifics, the initiative
May 11, 2018 by Chain Drug Review
CVS Health, President Donald Trump, Rising drug, Walgreens
Featured Articles, Leading Headlines, Pharmacy, Retail News

WASHINGTON — CVS Health and Walgreens have commended President Trump for vowing in a speech today to fight high drug prices. Issuing a sweeping plan to bring down prices, Trump again castigated drug manufacturers, while spreading blame to PBMs, wholesalers, foreign governments and his predecessors in Washington. “Everyone involved in the broken system — the drugmakers, insurance
March 19, 2018 by Chain Drug Review
Alex Azar, Every Prescription Conveyed Securely Act, Kevin Nicholson, Melania Trump, NACDS, National Association of Chain Drug Stores, opioid abuse, President Donald Trump, Steve Anderson, White House Opioid Summit
2018, Issue 03-19-2018, Issues, News

ARLINGTON, Va. — The National Association of Chain Drug Stores took part in this month’s White House Opioid Summit as it continues to give retail pharmacy’s take on how to combat the opioid abuse epidemic. Kevin Nicholson, vice president of public policy and regulatory affairs at NACDS, represented the association at the March 1 event,
February 12, 2018 by Greg Jacobson and Chain Drug Review
Alex Azar, Eli Lilly, Food and Drug Administration, HHS secretary, prescription drug prices, President Donald Trump, Secretary of Health and Human Services, State of the Union, Trump's State of the Union address
2018, Issue 02-12-2018, Issues, Leading Headlines, News, Pharmacy, Retail News

WASHINGTON — In his first State of the Union speech, President Donald Trump renewed his pledge to reduce prescription drug prices, days after a former big pharma executive was sworn in as Secretary of Health and Human Services. Trump had stunned the pharmaceutical industry during his 2016 campaign by declaring that drug manufacturers were “getting
November 14, 2017 by Chain Drug Review
Alex Azar, ational Community Pharmacists Association, B. Douglas Hoey, Bernie Sanders, Eli Lilly, HHS secretary, Lamar Alexander, Lilly USA, President Donald Trump, secretary of the U.S. Department of Health and Human Services, Tom Price
Featured Articles, Leading Headlines, Pharmacy, Retail News

WASHINGTON — Biopharmaceutical industry executive Alex Azar has been nominated as secretary of the U.S. Department of Health and Human Services (HHS) to fill the post vacated by Tom Price. Azar is currently founder and chairman of Seraphim Strategies LLC, an Indianapolis-based consultancy focused on the biopharma and health insurance industries, including biopharmaceutical sales, marketing, pricing,
November 2, 2017 by Chain Drug Review
B. Douglas Hoey, Chris Christie, Healthcare Distribution Alliance, John Gray, National Association of Chain Drug Stores, National Community Pharmacists Association, opioid abuse, opioid crisis, President Donald Trump, President's Commission on Combating Drug Addiction and the Opioid Crisis, Steve Anderson, video
Featured Articles, Leading Headlines, Pharmacy, Retail News, Videos

WASHINGTON — The President’s Commission on Combating Drug Addiction and the Opioid Crisis has issued its final report, which includes 56 recommendations to the Trump administration to help fight opioid abuse. President Donald Trump formed the presidential commission, chaired by New Jersey Gov. Chris Christie (R.), in a March 29 executive order as a way
October 26, 2017 by Chain Drug Review
Commission on Combating Drug Addiction and the Opioid Epidemic, CVS Health, Healthcare Distribution Alliance, John Gray, John Hammergren, Larry Merlo, McKesson, Melania Trump, opioid abuse crisis, opioid abuse epidemic, President Donald Trump, President's Commission on Combating Drug Addiction and the Opioid Crisis, Stefano Pessina, video, Walgreens Boots Alliance
Leading Headlines, Pharmacy, Retail News, Videos

WASHINGTON — Following through on pledge made this summer, President Donald Trump has formally declared the nation’s growing opioid abuse epidemic as a public health emergency. In a press conference at the White House on Thursday, the president and First Lady Melania Trump announced the action, which has drawn plaudits from public officials and pharmacy
October 24, 2017 by Chain Drug Review
Commission on Combating Drug Addiction and the Opioid Epidemic, NACDS, National Association of Chain Drug Stores, opioid abuse, opioid abuse epidemic, opioid crisis, President Donald Trump, Steve Anderson
Leading Headlines, Pharmacy, Retail News

ARLINGTON, Va. — The National Association of Chain Drug Stores has made four policy proposals to help fight opioid abuse in a letter to President Donald Trump. NACDS said Tuesday that the proposals made in the letter to President Trump build on current collaborative efforts to address the opioid abuse epidemic while preserving quality patient
October 23, 2017 by Chain Drug Review
Commission on Combating Drug Addiction and the Opioid Epidemic, John Hammergren, McKesson, opioid abuse crisis, opioid epidemic, President Donald Trump
Leading Headlines, Pharmacy, Supplier News

SAN FRANCISCO — McKesson Corp. chairman and chief executive officer John Hammergren has endorsed President Donald Trump’s plan to designate the opioid abuse crisis as a national emergency. Trump this week is expected to formally declare the growing misuse and abuse of narcotic painkillers as a national emergency after saying this summer that he planned
October 23, 2017 by Bill Schiffner
Affordable Care Act, AHPs, association health plans, Chuck Schumer, health insurance, preexisting conditions, President Donald Trump, Trump executive order
2017, Issue 10-23-2017, Issues, Leading Headlines, News, Pharmacy, Retail News

WASHINGTON — After numerous failed attempts to repeal the Affordable Care Act, President Donald Trump has signed an executive order to relax standards on small businesses that band together to buy health insurance and may take steps to allow the sale of other health plans that skirt the health law’s requirements. The Trump executive order
October 9, 2017 by Geoff Walden and Chain Drug Review
Affordable Care Act, Bill Cassidy, Graham-Cassidy, John McCain, Lindsey Graham, Mitch McConnell, Obamacare, President Donald Trump, Rand Paul, Susan Collins
2017, Issue 10-09-2017, Issues, Leading Headlines, News, Pharmacy, Retail News

WASHINGTON — President Donald Trump said Obamacare would be repealed and replaced early next year, following the failure of the Senate’s latest effort to overturn the law. After the Senate pulled back from a vote on legislation that would have moved control of health insurance to the states, Trump said Republicans “have the votes” to
August 19, 2017 by Geoff Walden and Chain Drug Review
Affordable Care Act, Department of Health and Human Services, HealthCare.gov, Julie Mix McPeak, Lamar Alexander, Michael Consedine, Mitch McConnell, National Association of Insurance Commissioners, Obamacare, President Donald Trump, skinny repeal
2017, Issue 08-21-2017, Issues, Leading Headlines, News, Pharmacy, Retail News

WASHINGTON — The failed effort to overturn the Affordable Care Act has hardly erased doubts about the law’s short- and long-term viability. Already, the Trump administration has suspended contracts with two companies that have helped thousands of people in nearly a score of cities get health insurance under the statute. In ending the $22 million
August 15, 2017 by CDR Blog and Chain Drug Review
Brian Krzanich, Doug McMillon, Kenneth Frazier, Kevin Plank, President Donald Trump, protests in Charlottesville, Walmart
CDR Blog

Add Walmart’s Doug McMillon to the list of chief executives concerned about President Donald Trump’s response to the violent protests in Charlottesville, Va. In a statement posted Tuesday on a Walmart website, McMillon wrote, “The role we play in communities around the country to build a more diverse and inclusive society is more critical than